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DIFFERENCES IN RISK-TAKING IN A TRAUMA EXPOSED POPULATION 
RUTH ANNA VIEHOFF 
ABSTRACT 
Previous studies have shown that depression and posttraumatic stress disorder (PTSD) 
are associated with a variety of risk-taking behaviors.  However fewer studies have 
examined how comorbidity between the two disorders can differentially affect risk-
taking.  This study examined the relationship between depression, PTSD, past risk-
taking, and perceived benefits of risk to further determine how comorbidity affects risk 
behaviors.  It was expected that individuals who displayed symptoms of depression and 
PTSD would report more past risk-taking and associate greater benefits with taking risks.  
Depression symptoms were found to significantly predict past drug use. This suggests 
that comorbid individuals who report more depressive symptoms may be more likely to 
abuse substances.   
 
 
iv 
 
TABLE OF CONTENTS 
           Page 
ABSTRACT………………………………….………………………………………...iii 
LIST OF TABLES………………..……………………………………………………vi 
CHAPTER. 
I. INTRODUCTION.…………………………………................................1 
II.        REVIEW OF RELEVANT LITERATURE.……………….....................3 
                        2.1. Prevalence of Trauma………..……………………………………...3 
                  2.2. Risk-Taking and Trauma……….….………………………………..4 
                 2.3. PTSD ………………….………………....………………………....6 
                   2.4. Prevalence of PTSD….………...…………………………………...6 
                  2.5. Risk-Taking and PTSD...…….…………………………………......8 
                   2.6. MDD…………………………………………..……………...….....9 
                  2.7. Prevalence of MDD.…….…………..…………………………….11 
  2.8 Risk-Taking and MDD………………………………………….....12 
  2.9 Prevalence of Comorbidity………………………………………...13 
  2.10 Symptom Severity and Comorbidity……………………………..15 
v 
 
  2.11 Risk-Taking and Comorbidity………………...………………….16 
  2.12 Consequences of Risk-Taking........................................................18 
       III.      METHODS.................……..…………………………………….….....21 
              3.1. Participants……………………..………………………………….21 
              3.2. Measures………………………….…….…………………………21 
                        3.3. Procedure ……………………………………………….……...…23 
                        3.4. Statistical Analyses ……………………………………………….24 
       IV.      RESULTS……….……………………………………………………..25 
  4.1 Bivariate Correlations.......................................................................26 
  4.2 Multiple Regressions........................................................................28 
 V.       DISCUSSION…………...……………………………………………..32 
REFERENCES ………………………………………………………………………..35 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
LIST OF TABLES 
PAGE 
Table  
I. Bivariate correlations of expected benefits of risk, past risk behaviors, MDD, 
PTSD, and the interaction term......................………………..........................28 
II. Hierarchical regression that compares the relationship between MDD, PTSD, 
the interaction term, and past drug use.........................……………...............31 
 
 
 
   
 
 
 
 
 
 
 1 
 
 
 
 
 
 
 
CHAPTER I 
INTRODUCTION 
 
 
This study examined differences in risk-taking behavior in a trauma-exposed 
population.  For purposes of the current study, risk-taking behavior was defined as illicit 
substance use, alcohol abuse, and sexual risk-taking.  This study was undertaken to 
replicate and expand upon prior studies which examined depression (MDD), 
Posttraumatic Stress Disorder (PTSD) (Diagnostic and Statistical Manual of Mental 
Disorders-IV [DSM-IV-TR]; American Psychiatric Association [APA], 2000), and risk.  
Prior research regarding comorbidity and risk-taking behavior is scant, and conclusions 
drawn in these studies often do not corroborate one another.  The current study was 
believed to be the first of its kind to examine MDD, PTSD, and the comorbidity of these 
disorders in relation to more varied types of risk behavior.  The current study used a 
community sample.  This differs from previous studies, which were chiefly interested in 
one type of trauma (e.g., child abuse) or a specific group of trauma survivors (e.g., 
intravenous drug users) (Holmes, Foa, & Sammel, 2005; Plotzker et al., 2007).  
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Individuals with comorbid PTSD and MDD were expected to report more risk-
taking behaviors than other trauma survivors.  These individuals were also expected to 
perceive more benefits from risk-taking.  Bivariate correlations and multiple regressions 
were run to determine relationships between PTSD, MDD, past risk-taking behaviors, 
and benefits associated with risk.  These findings are important because this study 
examined risk-taking in comorbid individuals in a more comprehensive way than 
previous studies by taking into account illicit substance use, alcohol abuse, and sexual 
risk.  Using a community sample made these findings more representative than those of 
previous studies that examined specific types of trauma or groups of trauma survivors.  
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CHAPTER II 
REVIEW OF RELEVANT LITERATURE 
 
 
2.1 Prevalence of Trauma 
In a community survey over a third of young adults reported trauma exposure by 
early adulthood (Breslau et al., 1991).  A different study of trauma exposure found that 
roughly two-thirds of participants had experienced at least one trauma, with one-fifth of 
participants reporting exposure within the past year (Norris, 1992).  Almost 70% of 
women contacted via a national telephone survey had experienced a severe assault (e.g., 
rape, physical assault, etc.) within their lifetime (Resnick, Kilpatrick, & Dansky, 1993).  
In a separate study about 20% of Americans reported experiencing severe violence within 
their lifetime (Kilpatrick, Acierno, Resnick, Saunders, & Best, 1997).  These conflicting 
percentages, such as 20% and 70%, are likely attributed to measuring different subsets of 
the population, such as a general American sample and a sample of only women. 
 The National Comorbidity Survey (NCS) was the first study to examine nation-
wide trauma prevalence (Kessler, Sonnega, Bromet, Hughes, & Nelson, 1995).  In the 
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NCS, 60.7% of men and 51.2% of women reported at least one trauma in their lifetime.  
The majority of individuals reporting trauma had been exposed to multiple traumas.  
Witnessing a trauma, having one’s life threatened, and experiencing a natural disaster 
were the most commonly reported traumas.  The NCS used DSM-III criteria of a 
traumatic event, which were more restrictive as to what defined a trauma (Kessler et al., 
1995).  
 The DSM-IV criteria of a trauma were first used to evaluate trauma prevalence in 
1998 (Breslau et al.).  Almost 90% engaged in the telephone survey reported at least one 
trauma over the course of their lifetime. The average among participants was 4.8 traumas.  
Among traumas reported, traumatic assault (e.g., rape, physical assault, combat) was 
reported by 37.7% of participants, a traumatic personal injury or shocking event (e.g., 
life-threatening accident or illness, natural disaster) were experienced by 59.8%, 60% 
experienced the sudden death of a loved one, and another 62.4% dealt with a traumatic 
nonfatal experience that happened to a loved one (e.g., a family member’s rape or 
automobile accident) (Breslau et al., 1998). Although this study was extensive, only 
individuals who lived within the greater Detroit metropolitan area were surveyed 
(Breslau et al., 1998).  
 
2.2 Risk-Taking and Trauma 
 Both childhood sexual abuse and childhood physical abuse have been associated 
with risky sexual behavior (Molitor, Ruiz, Klausner, & McFarland, 2000).  HIV infected 
adults with childhood physical or sexual abuse histories reported more HIV-risk behavior 
than other HIV infected adults (e.g., greater number of partners, less condom use) 
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(Johnson & Harlow, 1996).  Women who experience intimate partner violence report 
engaging in sexual risk behaviors (Campbell et al., 2008).  
Five distinct trauma groups were examined to determine if type of trauma 
experienced in adolescence affected risky behavior in female college students (Green et 
al., 2005).  Those who were experiencing ongoing abuse, either physical or sexual, 
showed the most sexual risk behaviors, high rates of suicidality, and perpetration of 
violence.  Those who had been sexually assaulted once or experienced multiple single 
traumatic events also showed elevated risky sexual behaviors.  Those with a history of 
multiple single traumatic events also showed high rates of suicidality.  Those who had 
experienced a traumatic loss or a single physical assault showed no significantly elevated 
risky behaviors. 
 Trauma’s impact on risk-taking was measured through the Youth Risk Behavior 
Survey, which was administered to female high school students (Silverman, Raj, Mucci, 
& Hathaway, 2001).  Intimate partner violence was associated with sexual risk, 
suicidality, pregnancy, unhealthy weight control, and substance use.  Participants who 
experienced both physical and sexual assault by a partner were more likely to engage in 
all of the risky behaviors.  Those who were abused by partners were four to six times 
more likely to have been pregnant and were six to nine times more likely to display 
suicidality.  They also reported a younger age of first intercourse and a greater number of 
partners (Silverman et al., 2001).  While a connection between trauma and risk has been 
established, PTSD may mediate this relationship. 
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2.3 PTSD 
 The DSM-IV-TR defines PTSD as a type of anxiety disorder that occurs after 
experiencing a traumatic event, e.g., rape, physical assault, or automobile accident (APA, 
2000).  A traumatic event is defined as an event where the person experienced, witnessed, 
or was confronted with an event that involved actual or threatened death or severe injury, 
or a threat to the physical integrity of self or others (DSM-IV-TR; APA, 2000).  In order 
to meet the definition, the person’s response must involve intense fear, helplessness, or 
horror.  
 Following trauma, individuals often develop symptoms within the three core 
clusters of: 1. reexperiencing the trauma (e.g., flashbacks, nightmares, or being triggered 
by internal or external cues), 2. avoidance of thoughts or other stimuli associated with the 
event as well as numbing of emotional responsiveness, and 3. increased arousal (e.g., 
difficulty sleeping or concentrating, anger) and hypervigilance.  While many trauma 
victims initially experience these symptoms, those with PTSD must retain symptoms for 
at least one month.  Symptoms generally occur within three months following trauma 
(DSM-IV-TR; APA, 2000).  Survivors experienced a median duration of between 3 and 5 
years of PTSD symptoms associated with their most upsetting trauma (Kessler et al., 
1995).  
 
2.4 Prevalence of PTSD 
 Community-based studies in the DSM-IV-TR report that 8% of American adults 
have PTSD (APA, 2000).  Among 5,877 participants, lifetime prevalence of 7.8% was 
reported in the National Comorbidity Survey, a nationwide epidemiologic survey 
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(Kessler et al., 1995).  Kessler and colleagues (1995) noted that 5% of men and 10.4% of 
women met criteria for PTSD.  A study of adolescents reported six-month PTSD 
prevalence rates of 3.7% for males and 6.3% for females (Kilpatrick et al., 2003).   
A separate study evaluating those with trauma histories reported that the risk of 
obtaining PTSD from an individual’s most severe trauma was 13.6%, while the PTSD 
risk from another experienced trauma was 9.2% (Breslau et al., 1998).  This study 
reported 40 cases of PTSD for every 100 participants in the sample, and claimed that 
PTSD was concentrated within 12% of the population (Breslau et al., 1998).  This 12% is 
believed to experience 3.3 cases of PTSD over the course of the lifetime (Breslau et al., 
1998).  Subsequent studies have reported different prevalence rates.  A majority (79%) of 
trauma-exposed refugees reported PTSD (Ferrada-Noli, Asberg, Ormstad, Lundin, & 
Sundbom, 1998).  A large percentage of trauma-exposed female prisoners (33%) reported 
lifetime PTSD, while 15% had an active diagnosis (Hutton et al., 2001).  A majority 
(58%) of motor vehicle accident survivors reported PTSD (Blanchard, Buckley, Hickling, 
& Taylor, 1998). A majority (75%) of interpersonal violence victims met criteria for 
PTSD (Nixon, Resick, & Neshith, 2004).  Obviously these rates are varied and are 
contingent on the population and type of trauma experienced.  
 The DSM-IV-TR states that PTSD symptoms often last over a year (APA, 2000).  
A separate study found that a typical PTSD episode generally lasted over 7 years (Breslau 
et al., 1998).  The typical person reporting the average of 3.3 PTSD episodes is believed 
to experience over 20 years of symptomatology (Breslau et al., 1998).  
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2.5 Risk-Taking and PTSD 
 Risky behaviors are increasingly being examined in PTSD research, due to the 
prevalence of the risk behaviors evidenced by those with PTSD, as well as concerns 
regarding revictimization (Acierno, Resnick, Kilpatrick, Saunders, & Best, 1999; Smith 
et al., 2004).  The relationship between intimate partner violence induced PTSD, 
substance abuse, and high-risk sexual behaviors was explored in a sample of female 
abuse victims (Cavanaugh, Hansen, & Sullivan, 2010).  Women with PTSD were four 
times more likely than other victims to engage in high-risk sexual activity (e.g., 
unprotected sex with a risky partner, trading sex).  PTSD has previously been associated 
with HIV-risk behaviors such as intravenous drug use and prostitution (Stiffman et al., 
1992).  The relationship between PTSD and HIV-risk behaviors was examined in the 
behaviors of female prisoners in the five years prior to incarceration (Hutton et al., 2001).  
PTSD was found to be significantly associated with prostitution and receptive anal sex 
(Hutton et al., 2001).   
 The relationship between PTSD and substance abuse was explored in Vietnam 
veterans (Bremner, Southwick, Darnell, & Charney, 1996).  Participants generally began 
abusing alcohol and substances when PTSD symptoms first occurred, and increased use 
when PTSD symptoms worsened.  Participants reported use of marijuana, heroin, 
benzodiazepines, and alcohol to alleviate PTSD symptoms (Bremner et al., 1996).  
Substances are often used to reduce negative symptoms following trauma (Kilpatrick et 
al., 1997), and when negative symptoms increase, frequency of substance use is believed 
to increase (Kilpatrick et al., 2000).  The relationship between trauma, PTSD, and 
substance abuse was further clarified in a national telephone survey of adolescents 
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(Kilpatrick et al., 2000).  Those who had experienced physical or sexual assault, as well 
as those who witnessed violence, had an elevated risk of alcohol and substance abuse.  
PTSD also increased risk for marijuana use and abuse of hard drugs (Kilpatrick et al., 
2000).   
 
2.6 MDD 
 According to the DSM-IV-TR, Major Depressive Disorder (MDD) is a mood 
disorder that is characterized by the presence of at least one major depressive episode 
(APA, 2000).  A major depressive episode is defined as a period of at least two weeks 
where prevalent depressed mood (e.g., individual makes somatic complaints or is 
discouraged, irritable, hopeless, or sad) or loss of interest in activities (e.g., loss of 
interest, loss of enjoyment, social withdrawal) is noted.  Four out of seven additional 
symptoms must also be met.  These can include changes in weight or appetite, sleeping 
habits, and level of activity; a lack of energy; feelings of worthlessness or excessive guilt; 
an inability to concentrate or make decisions; or thoughts regarding death, suicidal 
ideation, or suicide attempts (APA, 2000).  No manic symptoms must be present to 
warrant a diagnosis of MDD.  Symptoms should be accompanied by significant distress 
to the individual or impairment in vital areas of functioning.  Symptoms should not result 
from substance use, a medical condition, or loss of a loved one. 
 Onset of a major depressive episode may be slow or sudden, with symptoms 
developing over days, weeks, or months.  The duration of a major depressive episode also 
varies, with an untreated episode generally lasting four months or more (DSM-IV-TR; 
APA, 2000).  In most cases (about two-thirds of the time), symptoms fully remit, and the 
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individual returns to their prior level of functioning.  In 20 to 30% of individuals, some 
symptoms remain for months to years, resulting in some level of distress or impairment.  
However these individuals do not meet full episode criteria and are considered partially 
remitted.  Partial remission is associated with greater risk of future episodes.  A minority 
of individuals (5-10%) display full major depressive episode criteria for two years or 
longer and are considered to have chronic MDD (DSM-IV-TR; APA, 2000).   
 Presence of a major depressive episode is sufficient to diagnose an individual with 
MDD, Single Episode.  However the major depressive episode must not be due to or in 
conjunction with Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, 
Psychotic Disorder Not Otherwise Specified, or Delusional Disorder.  The individual 
must also report no history of manic symptoms.  MDD will be diagnosed as recurrent if 
an individual reports two or more major depressive episodes within their lifetime.  For 
the episodes to be considered separate from one another, there must be a period of two 
months where the individual does not meet episode criteria.  
 The course of recurrent MDD also varies.  Some people have episodes that are 
isolated from one another by several years.  Others may have clusters of episodes that are 
closely grouped together, while others may have increased frequency of episodes as they 
age.  The number of previous major depressive episodes is predictive of one’s chance of 
developing a future episode.  About 60% of those who have experienced one episode can 
expect to develop another, while 70% of those with a history of two episodes will have a 
third.  Those with a history of three episodes will generally develop a fourth (90%).  
Follow-up studies reported in the DSM-IV-TR found that a year after major depressive 
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episode diagnosis, 40% of people still met episode criteria, 40% had recovered, and 20% 
were in partial remission (APA, 2000). 
 
2.7 Prevalence of MDD 
 The National Comorbidity Survey Replication (NCS-R) was administered to 
obtain accurate information about the prevalence of disorders according to DSM-IV 
criteria.  Kessler and colleagues (2003) examined the prevalence rates and correlates of 
MDD in a nationwide sample (N = 9,090).  The lifetime prevalence rate of MDD was 
16.2%, while 6.6% of participants had experienced MDD within the last year.  This 
means that 32 to 35 million Americans suffer from MDD within their lifetime, while 13 
to 14 million experienced MDD within the past year.  The average length of a major 
depressive episode was four months. The majority of those suffering from MDD in the 
last year (59.2%) experienced severe role impairment (Kessler et al., 2003).  These 
findings were replicated in a later study by the authors, which reported a lifetime 
prevalence rate of approximately 20% for American adults (Kessler, Berglund, Demler, 
Jin, & Walters, 2005). 
 Onset of MDD may take place at any age, although it often begins in the mid-20s 
(Kessler et al., 2005).  According to community samples, lifetime prevalence rates of 
MDD range from 10-25% for females and 5-12% in males (DSM-IV-TR; APA, 2000).  A 
separate community sample reported six-month MDD prevalence rates of 7.4% for 
adolescent males and 13.9% for adolescent females (Kilpatrick et al., 2003).  In a study 
of undergraduate females with varying levels of trauma exposure, a lifetime MDD 
prevalence rate of 33% was reported (Green et al., 2005).  Those who were currently 
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undergoing abuse and those who had been experienced to multiple individual traumas 
showed higher rates of MDD than other participants (Green et al., 2005).  Over half 
(54%) of women exposed to intimate partner violence presented with MDD (Nixon et al., 
2004). 
 
2.8 Risk-Taking and MDD 
The association between MDD and risky sexual behavior was examined in 
adolescents (Shrier, Harris, Sternberg, & Beardslee, 2001).  MDD symptoms were 
associated with not using a condom at last intercourse for males, with intensity of MDD 
symptoms directly relating to frequency of condom use.  MDD symptoms were related to 
prior sexually transmitted diseases (STDs) in females, with more severe MDD 
symptomatology increasing the risk of having a prior STD by two to over three times that 
of non-depressed peers.  Males with the most severe MDD symptoms were three times as 
likely as peers without MDD to have an STD history (Shrier et al., 2001). 
The relationship between multiple psychosocial variables (i.e., MDD, social 
support, stress) and risky sexual behavior was examined in a sample of young women 
aged 14 to 25 (Mazzaferro et al., 2006).  MDD, stress, and poor social support were all 
associated with risky sexual behaviors (e.g., multiple partners, infrequent condom use) 
and past sexually transmitted infections (Mazzaferro et al., 2006).  The association 
between MDD and HIV-related risky behaviors was also evaluated in men who have sex 
with men (Perdue, Hagan, Thiede, & Valleroy, 2003).  MDD within this population was 
related to having three or more sexual partners within the previous six months, however 
no independent relationship between MDD and risky sexual behaviors was noted.  Men 
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who have sex with men who engaged in risky behavior (unprotected sex within the last 
12 months) were more depressed than non-risk-takers (Strathdee et al., 1998).  
The relationships between MDD, suicidality, and risky behaviors (e.g., drug use, 
disordered eating) were examined in an adolescent population (Kandel, Raveis, & 
Davies, 1991).  MDD symptomatology was the most significant predictor of suicidal 
ideation.  Drug use was associated with suicidal ideation in females and attempts in both 
genders.  MDD led to drug use in females, which then elevated suicidality.  Although 
substances are used to alleviate MDD symptomatology, they can often exacerbate the 
preexisting problem.  MDD has been associated with smoking cigarettes (Breslau, Davis, 
Andreski, & Petersen, 1991) and substance use (Kessler et al., 1995). Those with a first-
degree relative with MDD have an increased risk of developing alcohol dependence 
(DSM-IV-TR; APA, 2000).  MDD has been associated with sharing syringes in a study 
of injection drug users (Perdue et al., 2003).  Another study found that the severity of 
MDD in this population was related to the frequency of sharing needles or syringes 
(Stein, Solomon, Herman, Anderson, & Miller, 2003). 
 
2.9 Prevalence of Comorbidity 
According to the NCS-R most with a lifetime history of MDD (72.1%) had a 
comorbid mental disorder, with 59.2% of these reporting an anxiety disorder (Kessler et 
al., 2003).  Those who experienced MDD in the last 12 months (78.5%) were also likely 
to be comorbid (Kessler et al., 2003).  The majority of those with MDD in the last year 
(64%) reported another disorder within the same year, with 57.5% reporting an anxiety 
disorder.  Comorbid anxiety disorders often appeared at an earlier age than MDD onset.  
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MDD rarely occurred in isolation (Kessler et al., 2003).  According to the original NCS 
48% with PTSD reported a diagnosis of lifetime MDD, with MDD occurring after PTSD 
onset in 53 to 78.4% of cases (Kessler et al., 1995).  While a minority (9.2%) of youth 
developed PTSD post-trauma, 36.6% with PTSD met criteria for comorbidity (Breslau et 
al., 1991).   
Almost 75% of adolescents diagnosed with PTSD had an additional disorder 
(Kilpatrick et al., 2003).  Interpersonal violence increased the risk of all diagnoses (e.g., 
PTSD, MDD, comorbidity), but it increased comorbidity risk more so than any disorder 
in isolation. Rates of PTSD cases occurring in isolation were rare (1.4%) when compared 
to MDD (6.5%) or substance abuse (4.9%) (Kilpatrick et al., 2003). 
Individuals with PTSD were compared to those with trauma history, and those 
without prior trauma to see if trauma increased MDD risk (Breslau, Davis, Peterson, & 
Schultz, 2000).  Those with PTSD had an elevated risk of MDD development, while this 
was not seen in other trauma victims.  Those with a prior MDD diagnosis were over three 
times as likely to develop PTSD among those with trauma history.  Risk of developing 
either disorder is due to a common vulnerability to both disorders in trauma victims.  
PTSD increases risk of MDD onset, while an active MDD diagnosis may increase an 
individual’s risk of PTSD after trauma (Breslau, Davis, Peterson, & Schultz, 1997).  
Having either disorder increases susceptibility of developing the other disorder (Breslau 
et al., 2000).   
A separate study examined MDD, PTSD, and comorbidity at 3 and 12 months 
post-trauma and found that most psychopathology could be characterized as a construct 
of traumatic stress (O’Donnell et al., 2004).  Comorbidity was attributed to a common 
 15 
 
vulnerability to both disorders.  PTSD and comorbidity were indistinguishable 
throughout the study, while MDD was considered its own construct in the short-term, but 
not long-term, state.  MDD symptoms were generally not considered due to a separate 
disorder (O’Donnell et al., 2004).  Both of these studies (Breslau et al., 2000; O’Donnell 
et al., 2004) are in contrast to the prior finding that MDD and PTSD are correlated but 
distinct responses to trauma (Blanchard et al., 1998).   
 
2.10 Symptom Severity and Comorbidity 
A majority (57.9%) of motor vehicle accident victims were diagnosed with PTSD, 
with 53% of these meeting criteria for comorbidity (Blanchard et al., 1998).  In 81.8% of 
cases, MDD followed the trauma.  Comorbid individuals reported more distress, more 
functional impairment, and lower likelihood of symptom remission within six months, 
when compared to peers with PTSD.  Those with more MDD symptomatology reported 
higher levels of worthlessness and suicidal ideation (Blanchard et al., 1998).   
Comorbid veterans have been compared to those with MDD only within a 
primary care environment (Campbell et al., 2007).  A significant minority (36%) of those 
with MDD were comorbid.  Those with comorbidity reported greater MDD severity, 
more suicidal ideation, poorer social support, and increased outpatient care.  These 
individuals had a poorer prognosis and delayed response to MDD treatment.   
A study by Green and colleagues (2006) examined the effects of comorbidity on 
MDD treatment.  A sizable minority of participants (33%) were comorbid.  Women with 
comorbidity reported more exposure to assault, more severe symptoms for both disorders, 
and more functional impairment.  While MDD treatment was effective, comorbid 
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individuals reported higher levels of distress and impairment throughout the yearlong 
study.  Improvement of MDD symptomatology was comparable in both groups (Green et 
al., 2006).  Comorbid individuals have shown a delayed response to MDD treatment 
when compared to peers with MDD (Hegel et al., 2005).  
The rate of impairment and disability was examined in comorbid refugees 
(Momartin, Silove, Manicavasagar, & Steel, 2004).  Those with comorbidity reported 
more severe PTSD symptoms and greater long-term impairment (e.g., more distress, 
more social and occupational impairment) when compared to those with PTSD.   A 
majority (56%) of comorbid individuals in this study presented with the most severe 
symptoms, compared to 36% with PTSD (Momartin et al., 2004).  Comorbid victims of 
intimate partner violence have reported greater levels of MDD and PTSD symptoms 
when compared to those with PTSD, as well as more maladaptive depressed cognitive 
styles than those without PTSD (Nixon et al., 2004).   
 
2.11 Risk-Taking and Comorbidity 
 The relationship between childhood sexual abuse, MDD, PTSD, and risky sexual 
behavior was examined in men aged 18 to 49 (Holmes, Foa, & Sammel, 2005).  
Childhood sexual abuse was associated with both diagnoses of MDD and PTSD.  
Childhood sexual abuse, PTSD, MDD, and some sociodemographic variables (e.g., age, 
race, sexual orientation) were all associated with an individual’s number of lifetime 
sexual partners.  All two-way interactions within the model, as well as the three-way 
interaction of childhood sexual abuse, PTSD, and MDD, were also associated with one’s 
number of partners.  Individuals with childhood sexual abuse history and diagnostic 
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comorbidity had an elevated number of lifetime sexual partners when compared to others.  
MDD, PTSD, and the comorbidity of both conditions serve as mediators and moderators 
in the relationship between childhood sexual abuse and sexual risk behaviors (Holmes et 
al., 2005).  MDD and PTSD have previously been associated with HIV-risk behavior in 
men without childhood sexual abuse histories (Stiffman et al., 1992).   
The roles of PTSD and MDD were examined in the relationship between 
childhood sexual abuse and HIV-risk in a sample of injection drug users (Plotzker, 
Metzger, & Holmes, 2007).  A minority (23%) of the sample reported MDD only, while 
53% presented with comorbidity.  Childhood sexual abuse history (56% of sample) was 
significantly associated with sex and drug-related HIV-risk behaviors, as well as 
comorbidity.  However, when comorbidity was placed in the model, childhood sexual 
abuse was no longer predictive of risk behaviors, and comorbidity was associated with 
these behaviors.  This indicates that a comorbid diagnosis mediated the relationship 
between childhood sexual abuse and HIV-risk in female injection drug users (Plotzker et 
al., 2007). 
 Individuals with childhood sexual abuse, MDD, and PTSD report more lifetime 
sexual partners (Holmes et al., 2005).  However, this study was only interested in 
establishing a link between childhood sexual abuse and risk.  Comorbidity also mediated 
the relationship between childhood sexual abuse and HIV-risk in a different study 
(Plotzker et al., 2007).  This study only examined intravenous drug users and was 
specifically interested in establishing a relationship between childhood abuse and risk.   
When examining prior studies, researchers generally did not use community 
samples, and the only study that does is specifically researching childhood sexual abuse 
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(Holmes et al., 2005).  None of the examined studies are representative to all types of 
trauma and all types of trauma survivors.  
 
2.12 Consequences of Risk-Taking 
 Risk-taking has been observed in populations with MDD, PTSD, and 
comorbidity.  Regardless of diagnostic category, risky behaviors can complicate an 
individual’s current treatment, prognosis, and safety.  As prior trauma and PTSD both 
already increase the likelihood of future revictimization (Acierno et al., 1999), it is 
probable that risky behavior would further exacerbate this risk. 
A study by Smith and colleagues looked at cognitions relating to risk behaviors in 
college women with or without trauma histories (2004).  Those who had experienced 
trauma perceived risk differently than those without trauma and reported greater 
likelihood of engaging in risky acts.  Those with adult sexual assault, childhood sexual 
abuse, and aggravated assault histories perceived greater benefits relating to drug use and 
risky sexual behaviors when compared to those without trauma.  Victims of adult and 
childhood sexual assault perceived less risk related to drug use and risky sexual acts 
when compared to those without trauma history.  All victims reported greater likelihood 
to engage in drug use and risky sex acts than those without trauma history.  Adult sexual 
assault victims also reported more perceived benefits of drinking and greater likelihood to 
engage in heavy drinking (Smith et al., 2004).   
Perceptions of risk and benefits were the only significant predictors for both drug 
use and risky sexual behaviors (Smith et al., 2004).  Benefits were most predictive of 
future involvement for both behaviors.  While cognitions were predictive of heavy 
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drinking, adult sexual assault itself also predicted alcohol use. Individuals’ cognitions 
directly mediated the relationship between victimization and involvement in risky 
behaviors.  PTSD symptoms are believed to contribute to involvement in risky behaviors 
(Smith et al., 2004). Trauma-related impairment in cognitions may lead an individual to 
improperly evaluate the risks and benefits of a situation, leading to increased involvement 
in risky behavior and greater revictimization risk (Smith et al., 2004).   
Trauma survivors’ increased likelihood to engage in risk behaviors and disparate 
perceptions regarding risk likely increase their chance of revictimization when compared 
to those without trauma histories.  While Smith and colleagues established a connection 
between trauma, perceptions, and risk-taking, it is unclear to what extent MDD, as well 
as comorbidity, further exacerbates this problem (2004).  The current study is pertinent to 
comorbid trauma survivors as this group may be disproportionately exposing themselves 
to risky behaviors and future revictimization.  Until this relationship is clarified, 
treatment cannot be effectively modified for this high-risk group of individuals.  
This study added to the current body of research regarding PTSD, MDD, and risk-
taking.  This study expanded on previous work by Holmes and colleagues (2005) in that 
it included participants not diagnosed with a disorder.  This was a benefit over the study 
by Plotzker and colleagues (2007) whose research design required comorbidity to be 
present.  This study used a community sample of trauma survivors.  A review of previous 
literature examining comorbidity and risk found that these studies rarely used community 
samples, instead basing findings on war veterans or intravenous drug users (Ferrada-Noli 
et al., 1998, Plotzker et al., 2007).  The one study that used a community sample was 
explicitly trying to link childhood sexual abuse to HIV-risk (Holmes et al., 2005).  Prior 
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findings are not representative of all types of trauma or all types of trauma survivors.  
This study presented more representative findings of the relationship between MDD, 
PTSD, and risk.  
Involvement in risky behaviors and potential benefits associated with these 
behaviors were assessed in a trauma-exposed population.  Individuals were compared 
using diagnostic measures and a measure of risk-taking.  The Beck Depression Inventory 
(BDI; Beck, Ward, Mendelson, Mock, & Erbauch, 1961) and the Posttraumatic 
Diagnostic Scale (PDS) (Foa, Cashman, Jaycox, & Perry, 1997) were the two diagnostic 
measures used in this study.  Comorbid individuals were expected to show more MDD 
and PTSD symptoms than individuals with symptoms of either disorder.  Those with 
comorbidity were expected to engage in more risk-taking behaviors as measured by the 
Cognitive Appraisals of Risky Events than individuals with either MDD or PTSD 
symptoms (CARE-R; Fromme, Katz, & Rivet, 1997).  Comorbid individuals were 
hypothesized to exhibit more high-risk behaviors and perceive more benefits from these 
behaviors than individuals with either MDD or PTSD symptoms.  
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CHAPTER III 
METHODS 
  
 
3.1 Participants 
 A community sample was used for this study.  Participants responded to 
newspaper ads or flyers to join the study.  In order to qualify, participants were required 
to have experienced or witnessed an event which involved actual or threatened death or 
serious injury, or a threat to the physical integrity of self or others.  A participant’s 
response must have involved intense fear, helplessness, or horror (DSM-IV-TR; APA, 
2000).  The sample size was 136, with 70 females (51.5%) and 66 males (48.5%).  
Participants had a mean age of 40.85 (SD = 17.87), and ranged in age from 18 to 69.   
 
3.2 Measures 
Demographics: A brief demographic questionnaire was given to gather information 
regarding gender, age, and ethnicity.  
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Posttraumatic Diagnostic Scale (PDS; Foa, Cashman, Jaycox, & Perry, 1997): The PDS 
is a measure used to diagnose PTSD and trauma history.  Items are written to reflect the 
diagnostic criteria for PTSD in the DSM-IV-TR.  The presence of hyperarousal, 
avoidance, and/or reexperiencing symptoms is assessed, as well as the severity of noted 
symptoms. The participant’s level of impairment due to symptoms is also measured.  The 
measure is comprised of 17 symptom items.  A Likert scale is used, with responses 
ranging from zero to three, or from “not at all” to “5 or more times a week.”  Items are 
summed to get a total symptom severity score, with a score of 25 or higher equating to an 
approximate PTSD diagnosis.  Symptom severity could range from 0 to 51.  The PDS has 
similar reliability (α = 0.78 – 0.92) and validity (α = 0.82) to other PTSD measures (Foa 
et al., 1997). 
 
Cognitive Appraisal of Risky Events (CARE-R; Fromme, Katz, & Rivet, 1997): The 
CARE-R assesses a participant’s involvement in risky sexual behavior, alcohol use, and 
drug use within the previous six months.  The CARE-R also measures the person’s 
perceptions of risks and benefits related to each behavior.   A Likert scale is used to 
assess benefits, with responses ranging from one to seven, or from “not at all likely” to 
“extremely likely.”  Frequency of past risk is assessed through a participant’s self-report 
of the number of times he took part in a behavior in the past six months.  Separate scores 
are created for the expected risks, benefits, and past frequency of each risky behavior.  
Nine scores are created in total.  Good predictive validity has been reported (up to six 
months), as well as high reliability (α = 0.86) (Fromme, Katz, & D’Amico, 1997). 
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Beck Depression Inventory (BDI; Beck, Ward, Mendelson, Mock, & Erbauch, 1961): 
The BDI is a measure used to diagnose MDD.  Items are written to reflect the diagnostic 
criteria for a major depressive episode in the DSM-IV-TR.  The key symptom of sadness 
or loss of interest is noted, as well as all other major depressive episode symptoms.  The 
participant’s level of functional impairment is also noted.  The measure is comprised of 
21 symptom items.  A Likert scale is used, with responses ranging from zero to three, 
with scores of three indicating more severe depressive symptoms.  Items are summed to 
get a symptom severity score, with a score of 14 equating to a diagnosis of mild MDD.  
Symptom severity could range from 0 to 63.  The BDI has good reliability (α = 0.81 – 
0.86) and validity (α  = 0.72) (Beck, Steer, & Carbin, 1988). 
 
3.3 Procedure 
 Participants were recruited through flyers and newspaper ads.  In order to take 
part in the study, participants were required to have experienced at least one trauma.  The 
informed consent process was explained, and participants were made aware that 
involvement in the study was voluntary.  Participants were given a number of self-report 
questionnaires.  Traumatic history and current PTSD and MDD symptoms were assessed.  
While the questionnaires do not attempt to diagnose an individual with either MDD or 
PTSD, they do assess the DSM-IV-TR criteria pertaining to each disorder, thus 
diagnostic status could be estimated for purposes of the current study.  Participants’ past 
history and perceived risks and benefits concerning risky sexual behavior, drug use, and 
alcohol use were assessed.  Demographic information regarding the participant was also 
obtained.  Each individual who took part in the study received $20 as compensation. 
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 Based on responses to the PDS and BDI, participants either displayed no 
psychopathology, PTSD symptoms, MDD symptoms, or symptoms of both disorders.  
MDD symptoms and PTSD symptoms were considered to be two separate continuous 
variables.  MDD and PTSD symptoms were multiplied to create a continuous variable for 
comorbidity.  These variables were then compared with regard to involvement in risky 
behaviors and benefits of risky behaviors.   
 
3.4 Statistical Analyses 
Approximately half of participants were expected to have PTSD, with half of 
these having MDD symptoms as well.  A smaller group of participants was expected to 
have MDD symptoms only.  
Multiple regressions and bivariate correlations were run to examine the 
relationship between PTSD, MDD, benefits of risk, and past risk-taking behaviors.  
Individuals were compared on past risk involvement and perceived benefits of risk.  PDS 
scores and BDI scores were entered at the same time to determine the unique effects of 
each on past involvement and benefits of substance use, alcohol use, and risky sexual 
behaviors.  PDS and BDI were multiplied to create an interaction term, which was 
entered into the second step of a hierarchical regression.  The interaction term tells what 
the comorbidity contributes above and beyond the contribution of either MDD or PTSD.  
Six hierarchical regressions were run for each of the six dependent variables.  Because of 
the number of analyses that were run, I chose to have a more conservative  entry level 
(.025), as well as a more conservative  removal level (.05).  
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CHAPTER IV 
RESULTS 
  
 
 Participants were exposed to a wide range of traumas, and almost all (N = 128, 
94.1%) were exposed to multiple traumas.  Most commonly reported traumas were 
serious accident (N = 89, 65.4%), non-sexual assault by a stranger (N = 73, 53.7%), non-
sexual assault by someone the participant knew (N = 72, 52.9%), sexual assault by 
someone they knew (N = 57, 41.9%), and sexual contact when younger than 18 with 
someone 5 or more years older (N = 57, 41.9%).  Other traumas reported were 
imprisonment (N = 45, 33.1%), sexual assault by a stranger (N = 43, 31.6%), life-
threatening illness (N = 27, 19.9%), natural disaster (N = 23, 16.9%), torture (N = 10, 
7.4%), and being in military combat or a war zone (N = 9, 6.6%).   
Participants’ PDS scores ranged from 0 to 51, while BDI scores ranged from 0 to 
44.  Based on participants’ PDS scores, 74 met diagnostic criteria for PTSD.  Based on 
BDI scores, 85 participants met diagnostic criteria for MDD.  Almost half of participants 
(N = 58, 42.6%) met diagnostic criteria for both disorders. 
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Participants’ mean scores for past frequency of alcohol use (M = 1.14), drug use 
(M = .52), and risky sexual behaviors (M = .89) were compiled.  Participants engaged in 
risky behaviors infrequently, and engaged in risky alcohol use about once every six 
months.  Drug use and risky sexual behaviors were reported less frequently, as 
participants’ reported average values of engaging less than once in the past six months.  
Mean scores for expected benefits of alcohol use (M = 2.05), drug use (M = 1.52), and 
risky sexual behaviors (M = 2.62) were also compiled.  Participants reported a low 
likelihood of positive consequences for alcohol use and drug use.  Participants reported 
the likelihood of positive consequences for risky sexual behaviors to be moderately 
likely.  
 
4.1 Bivariate Correlations 
 Correlations were run to examine relationships between past risky behaviors, 
benefits of risk, PTSD, MDD, and the comorbidity of these disorders.  Past risky sexual 
behaviors were significantly correlated with past drug use and alcohol use.  Past drug and 
alcohol use were also significantly correlated with one another.  Expected benefits of 
risky sexual behavior were significantly correlated with expected benefits of drug use and 
alcohol use.  Expected benefits of alcohol use and drug use were also significantly 
correlated.  Each expected benefit significantly correlated with its corresponding past use 
behavior.  
BDI scores were significantly correlated with past drug use (r = .229, p < .01).  
BDI scores were nearing a significant correlation with past alcohol use (r = .184, p < .05).  
There was a non-significant correlation of .154 (p = n.s.) between BDI and past risky 
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sexual behaviors.  BDI scores were not significantly correlated with expected benefits of 
risky sex (r = .019, p = n.s.), drug use (r = -.009, p = n.s.), or alcohol use (r = .071, p = 
n.s.).  
Symptom severity of PTSD was not significantly correlated with past risky sexual 
behaviors (r = .140, p = n.s.), past drug use (r = .101, p = n.s.), or past alcohol use (r = 
.106, p = n.s.).  Symptom severity of PTSD was not significantly correlated with 
expected benefits of risky sex (r = -.107, p = n.s.), drug use (r = -.033, p = n.s.), or 
alcohol use (r = .055, p = n.s.).  
BDI scores and symptom severity of PTSD were significantly correlated with one 
another (r = .564, p < .01).  However the interaction of these two items did not 
significantly correlate with any of the expected benefits of risk or past risk-taking 
behaviors.   
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Table 1 
 
Bivariate correlations of expected benefits of risk, past risk behaviors, MDD, PTSD, and 
the interaction term 
 
 EBAlc. EBDrug EBSex PastAlc. PastSex PastDrug Interact PTSD 
EBAlc. - .540
**
 .492
**
 .572
**
 .226
**
 .157 .082 .055 
EBDrug .540
**
 - .507
**
 .200
*
 .047  .319
**
 .005 -.033 
EBSex .492
**
 .507
**
 -  .205
*
 .232
**
 .165 -.032 -.107 
PastAlc. .572
**
  .200
*
 .205
*
 -  .395
**
 .513
**
 .131 .106 
PastSex  .226
**
 .047  .232
**
 .395
**
 -  .319
**
 .108 .140 
PastDrug .157  .319
**
 .165  .513
**
  .319
**
 - .147 .101 
Interact. .082 .005 -.032 .131 .108 .147 - .783
**
 
PTSD .055 -.033 -.107 .106 .140 .101 .783
**
 - 
BDI .071 -.009 .019  .184
*
 .154  .229
**
  .897
**
 .564
**
 
** Correlation is significant at the 0.01 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed). 
 
4.2 Multiple Regressions 
 Although the interaction term did not significantly correlate with risks or benefits,  
 
six exploratory hierarchical regressions were run to further examine the relationship.   
 
First, PTSD symptom severity and BDI scores were entered into the model to determine  
 
if they significantly predicted past total risk and expected benefits.  For each analysis, the  
 
interaction term was then added in the second step to determine if it accounted for more  
 
of the variance in the relationship than PTSD and MDD had on their own.  
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PTSD and BDI symptom severity accounted for 2.3% of the variance in past risky 
sexual behaviors (R
2
=.023, F(2,127)=1.463, p=n.s.).  BDI score did not significantly 
predict past risky sex (β = .004, p = n.s.), nor did PTSD symptom severity (β = .006, p = 
n.s.).  The addition of the interaction term accounted for 3.4% of the variance (R
2
=.034, 
F(3,126)=1.462, p=n.s.).  The BDI score (β = .021, p = n.s.), PTSD symptom severity (β 
= .014, p = n.s.) and interaction term did not significantly predict past risky sex (β = -
.001, p = n.s.). 
PTSD and BDI symptom severity accounted for 4.9% of the variance in past drug 
use (R
2
=.049, F(2, 127)=3.245, p < .05).  BDI score significantly predicted past drug use 
(β = .016, p < .025), while PTSD symptom severity did not (β = -.002, p = n.s.).  The 
addition of the interaction term accounted for 6.4% of the variance (R
2
=.064, 
F(3,126)=2.891, p < .05).  This accounted for more variance and was closer to 
significance than the previous model.  BDI score significantly predicted past drug use (β 
= .035, p < .025), while PTSD symptom severity (β = .007, p = n.s.) and the interaction 
term did not (β = -.001, p = n.s.). 
PTSD and BDI symptom severity accounted for 2.8% of the variance in past 
alcohol use (R
2=.028, F(2,127)=1.850, p=n.s.).  BDI score (β = .020, p = n.s.) and PTSD 
symptom severity (β = .002, p = n.s.) did not significantly predict past alcohol use.  The 
addition of the interaction term accounted for 3.6% of the variance (R
2
=.036, 
F(3,126)=1.559, p=n.s.).  BDI score (  = .047, p = n.s.), PTSD severity (  = .014, p = 
n.s.), and the interaction term (  = -.001, p = n.s.) did not significantly predict past 
alcohol use.  
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PTSD and BDI symptom severity accounted for 1.7% of the variance in expected 
benefits of sex (R
2 
= .017, F(2,127)=1.120, p=n.s.).  BDI score (  = .008, p = n.s.) and 
PTSD symptom severity (  = -.012, p = n.s.) did not significantly predict expected 
benefits of sex.  The addition of the interaction term accounted for 2.0% of the variance 
(R
2 
= .020, F(3,126)=.840, p=n.s.).  BDI score (  = -.002, p = n.s.), PTSD severity (  = -
.016, p = n.s.), and the interaction term (  = .000, p = n.s.) did not significantly predict 
expected benefits of risky sexual behavior.  
 PTSD and BDI symptom severity accounted for 0.2% of the variance in expected  
 
benefits of drug use (R
2
=.002, F(2,127)=.107, p=n.s.).  BDI score (  = -.001, p = n.s.) and 
PTSD symptom severity (  = -.003, p = n.s.) did not significantly predict expected 
benefits of drug use.  The addition of the interaction term accounted for 2.1% of the 
variance (R
2
=.021, F(3,126)=.880, p=n.s.).  BDI score (  = -.031, p = n.s.), PTSD 
severity (  = -.017, p = n.s.), and the interaction term (  = .001, p = n.s.) did not 
significantly predict expected benefits of drug use.   
 PTSD and BDI symptom severity accounted for .04% of the variance in expected 
benefits of alcohol use (R
2
=.004, F(2,127)=.272, p=n.s.).  BDI score (  = .004, p = n.s.) 
and PTSD symptom severity (  = .005, p = n.s.) did not significantly predict expected 
benefits of alcohol use.  The addition of the interaction term accounted for 1.0% of the 
variance (R
2
=.010, F(3,126)=.422, p=n.s.).  BDI (  = -.021, p = n.s.), PTSD (  = -.007, p 
= n.s.), and the interaction term (  = .001, p = n.s.) did not significantly predict expected 
benefits of alcohol use.  
 Past risk-taking behaviors were significantly correlated with one another, as were 
expected benefits of risk.  Expected benefits of a risk-taking behavior also correlated 
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significantly with the corresponding past behavior.  BDI scores were significantly 
correlated with past drug use, and were nearing significance in the correlation with past 
alcohol use.  PTSD symptom severity was not significantly correlated with any expected 
benefits or past risk behaviors.  BDI and PTSD were significantly correlated with one 
another, however the interaction term did not significantly correlate with any past use or 
benefits.  When examining multiple regressions, BDI score significantly predicted past 
drug use, both when it was entered with PTSD severity, as well as when it was entered 
with the interaction term.  BDI and PTSD scores accounted for a percent of the variance 
(4.9%) in past drug use that was nearing significance, while the addition of the interaction 
term also contributed a percent of the variance (6.4%) in past drug use that was nearing 
significance.  
 
 
Table 2 
 
Hierarchical regression that compares the relationship between MDD, PTSD, the 
interaction term, and past drug use 
 
Step Predictors R R
2
  R
2
 β t Sig. 
1 BDI .220 .049 .049 .016 2.308 .023* 
 PTSD    -.002 -.410 .682 
2 BDI .254 .064 .016 .035 2.366 .019* 
 PTSD    .007 .837 .404 
 Interaction    -.001 -1.458 .147 
 
Note. PTSD = total score of 17 PTSD symptomatology items (PDS), BDI = total score of 
21 MDD symptomatology items (BDI), Interaction was created by multiplying the PTSD 
and BDI terms together. 
 
* Correlation is significant at the 0.025 level (2-tailed). 
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CHAPTER V 
 
DISCUSSION 
 
 
 
 
 
 These research findings could have important implications for treatment of 
comorbid PTSD and MDD.  While a new edition of the Diagnostic and Statistical Manual 
of Mental Disorders is going to be released, risk is still not considered to be a criterion for 
either PTSD or MDD.  Clinicians often do not assess for risk when treating clients with 
these disorders.  These research findings underscore the importance of properly assessing 
for risk behaviors when treating those with PTSD or MDD.  In the current study, MDD 
was more predictive of past risk than PTSD.  This suggests that clients with more severe 
MDD symptoms engage in more drug use than clients whose MDD symptoms are less 
severe.  While comorbid clients often present similarly, this study indicates that those 
with more depressive symptoms may be more likely to take part in risk-taking when 
compared to those with more PTSD symptoms.  Comorbid clients should be treated for 
both disorders, with the understanding that if depression is the predominant disorder, 
risk-taking may be elevated.  This should be assessed for and attended to appropriately in 
treatment.   
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 While PTSD did not correlate with other variables, there are likely multiple 
reasons for this.  A community sample is likely to experience less distress and 
impairment in functioning than an inpatient sample.  As these participants are functioning 
within their community, they may be suffering less than participants from an inpatient 
sample in general.  This likely lead to fewer reports of past use and less associated 
benefits with risk for participants with PTSD.  In addition, the measure used for PTSD 
may not have accurately recorded participants’ symptoms, severity, or impairment in 
functioning.  Furthermore, those with MDD or PTSD may be engaging in risk-taking 
behaviors which were not measured through the CARE-R.  These individuals may exhibit 
a range of withdrawal behaviors, including withdrawing from their work environment, 
home life, or social life.  Inclusion of withdrawal behaviors may have more accurately 
displayed the relationship between risk, benefits, and diagnosis.   
In the future fewer analyses should be run, so that an α level of .05 may be 
observed.  Increasing sample size may also make it more likely that significant effects 
will be found.  MDD and PTSD were found to be highly correlated with one another (r = 
.564, p < .01), and there may have been too much multicollinearity between the two 
measures to accurately differentiate effects using the interaction term.  
 As past drug use, alcohol use, and risky sexual behavior are highly correlated with  
 
one another, it may be advantageous to simply create an aggregate measure of past risk.    
 
This could be done by converting each risk variable into a standard score and then adding  
 
the variables together to create a composite value.  As expected benefits are highly  
 
correlated with one another, an aggregate measure of benefits could easily be created as  
 
well.  As expected benefits are on the same scale, they could simply be summed to create  
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a composite expected benefits score.   Creating aggregate measures would allow  
 
researchers to look at the relationship between benefits, past use, PTSD, and MDD in a  
 
simpler and cleaner way. 
 
 Given that the interaction term did not significantly predict any past use or  
 
benefits, it is probable that the relationship between MDD and PTSD is not  
 
multiplicative.  Future research should be done using either MDD or PTSD as a mediator  
 
for the model between a diagnosis and expected benefits and past risk.   
 
 Future research should also examine how severity of symptoms of MDD and  
 
PTSD differentially affects benefits of risk and past risk-taking behaviors.  Those with  
 
low severity symptoms should be compared to those with high severity symptoms to  
 
determine how this may affect risk.  Shifting to a focus on severity will give researchers a  
 
more authentic look at this relationship.  Given that MDD is more predictive of past drug  
 
use, it is likely that symptom severity impacts the relationship between diagnosis and  
 
risk-taking in a very meaningful way.   
 
 A weakness of this study was a failure to conceptualize comorbidity in multiple  
 
ways.  A strength of this study was the ability to compare trauma survivors.  The ability  
 
to look exclusively at a trauma-survivor population allowed this research to look at PTSD  
 
and comorbidity in a more controlled way than would be possible in a non-trauma  
 
sample. 
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